Pharma company summoned in drug racket case

April 20, 2016 12:00 am | Updated 05:40 am IST - Mumbai:

The Thane Police have summoned directors of Avon Lifesciences in connection with the ephedrine trafficking racket that was busted last week. The Thane Crime Branch had arrested five persons and seized ephedrine worth Rs 2,000 crore. The drugs were seized from a godown belonging to Avon Lifesciences in Solapur.

“We have issued summonses to all directors of the company, asking them to come and give us details needed for the investigation. So far, the probe indicates that only Avon was involved in the racket,” said Additional Commissioner of Police (Crime) Makarand Ranade, Thane Police.

The police have expanded the scope of their investigation, bringing all the offices and godowns of the company under their scanner. “We are examining all the premises owned by the company for further leads,” said Thane Police Commissioner Param Bir Singh. Officials said they have identified at least three persons who were allegedly brought in by Avon to run the ephedrine racket, and that these three suspects have made several foreign trips till now. The trio are suspected of having facilitated transport of around 100 kilograms of ephedrine from the godown in Solapur to a location out of Maharashtra, and this angle is being probed.

“We have provided details of our investigation to Central agencies like the Narcotics Control Bureau, and they are probing to find out whether other such pharma companies are involved in the illegal drug trade,” an officer said.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.